Markus Reitmajer

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Machine Learning

Chronic Kidney Disease

Ejection Fraction

Top Venues

Journal of cancer research and clinical oncology

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Reitmajer, Ulrike Leiter, Lena Nanz, Teresa Amaral, Lukas Flatz, Claus Garbe, Andrea Forschner
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017. Journal of cancer research and clinical oncology 150 (1) (2024)
Markus Reitmajer, Ulrike Leiter, Lena Nanz, Teresa Amaral, Lukas Flatz, Claus Garbe, Andrea Forschner
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017. Journal of cancer research and clinical oncology 150 (1) (2024)
Markus Reitmajer, Ulrike Leiter, Lena Nanz, Teresa Amaral, Lukas Flatz, Claus Garbe, Andrea Forschner
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017. Journal of cancer research and clinical oncology 150 (1) (2024)
Markus Reitmajer, Ulrike Leiter, Lena Nanz, Teresa Amaral, Lukas Flatz, Claus Garbe, Andrea Forschner
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017. Journal of cancer research and clinical oncology 150 (1) (2024)
Markus Reitmajer, Stephan Forchhammer, Toni Silber
Successful treatment of CARD14-negative juvenile Pityriasis rubra pilaris with Ustekinumab. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)